Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Despite over two decades of research and widespread use in biohacking communities, BPC-157 has not been associated with any serious adverse events in available literature and user reports
Lower starting doses also help distinguish peptide effects from coincidental events
When B12 is low, patients may experience fatigue, weakness, numbness, tingling, balance problems, anemia, cognitive changes, or neuropathy-like symptoms
It remains a research compound that some clinics and individuals have begun using despite the lack of regulatory approval
It is used in adults for the long-term treatment of anemia caused by vitamin B12 deficiency (called pernicious anemia) after blood levels have been brought back to normal through treatment with vitamin B12 injections.
US$ 28.54
US$ 22.13
US$ 26.40
